Cargando…

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?

Most patients present for catheter ablation of atrial fibrillation (CAAF) with residual or full effect of vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs). In daily practice, it has been observed that the activated clotting time (ACT) was actually poorly sensitive to the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hardy, Michael, Douxfils, Jonathan, Dincq, Anne-Sophie, Sennesael, Anne-Laure, Xhaet, Olivier, Mullier, Francois, Lessire, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001940/ https://www.ncbi.nlm.nih.gov/pubmed/35425821 http://dx.doi.org/10.3389/fcvm.2022.864899

Ejemplares similares

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests
por: Favresse, Julien, et al.
Publicado: (2018)

An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve
por: Cao, Yalin, et al.
Publicado: (2022)

Effectiveness and Safety of DOACs in Atrial Fibrillation Patients Undergoing Catheter Ablation: Results from the China Atrial Fibrillation (China-AF) Registry
por: Dong, Zhimin, et al.
Publicado: (2022)

Effectiveness and Safety of DOACs vs. Warfarin in Patients With Atrial Fibrillation and Frailty: A Systematic Review and Meta-Analysis
por: Zeng, Shan, et al.
Publicado: (2022)

Prescription of DOACs in Patients with Atrial Fibrillation at Different Stages of Renal Insufficiency
por: Hahn, Kai, et al.
Publicado: (2023)

Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Gao, Xinxing, et al.
Publicado: (2021)

DOAC in COVID-19: Yes or No?
por: Schutgens, Roger E.
Publicado: (2020)

Adverse Events of DOACs in Children
por: Bosch, Alessandra, et al.
Publicado: (2022)

DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation
por: Margetić, Sandra, et al.
Publicado: (2022)

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
por: Cappato, Riccardo, et al.
Publicado: (2015)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Which Renal Function Equation Should Be Used for Prescribing DOACs in Patients With Atrial Fibrillation?
por: Wang, Yilong, et al.
Publicado: (2022)

DOACs – advances and limitations in real world
por: Lee, Lai Heng
Publicado: (2016)

DOAC drug interactions management resource
por: Chadha, Ayush, et al.
Publicado: (2022)

Antithrombotic treatment patterns in patients with atrial fibrillation in Italy pre- and post-DOACs: the REPAIR study
por: Esposti, Luca D, et al.
Publicado: (2019)

A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC
por: Blin, Patrick, et al.
Publicado: (2015)

The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC
por: Abdrakhmanov, Ayan, et al.
Publicado: (2023)

Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests
por: Lessire, Sarah, et al.
Publicado: (2016)

Bariatric Surgery can Lower the Efficacy of DOACs
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2020)

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
por: Sehrawat, Ojasav, et al.
Publicado: (2023)

The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization
por: Gosselin, Robert C., et al.
Publicado: (2022)

New Direct Oral Anticoagulants (DOAC) and Their Use Today
por: Schwarb, Heike, et al.
Publicado: (2016)

DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

DOACs and rheumatic valvulopathy: always a red light?
por: Rochira, Carla, et al.
Publicado: (2023)

Spontaneous rectal sheath bleed while on DOAC anticoagulation
por: de Courcy, Louis, et al.
Publicado: (2023)

Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis
por: Emanuel, Subo, et al.
Publicado: (2023)

Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies
por: Liu, Fuwei, et al.
Publicado: (2021)

Safety and Efficacy of Uninterrupted Oral Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation with Different Techniques
por: Schiavone, Marco, et al.
Publicado: (2023)

Optimization of DOAC management services in a centralized anticoagulation clinic
por: Sylvester, Katelyn W., et al.
Publicado: (2022)

Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data
por: Moret, Carla, et al.
Publicado: (2023)

Safety and efficacy of uninterrupted treatment with edoxaban or warfarin during the peri‐procedural period of catheter ablation for atrial fibrillation
por: Naito, Kazuya, et al.
Publicado: (2020)

Uninterrupted Direct Oral Anticoagulants Without a Change in Regimen for Catheter Ablation for Atrial Fibrillation Is an Acceptable Protocol
por: Oshima, Tsukasa, et al.
Publicado: (2021)

Comparison of Interrupted and Uninterrupted Anticoagulation Therapy for Patients With Atrial Fibrillation Undergoing Catheter Ablation: A Meta-Analysis
por: Jamil, Sidra, et al.
Publicado: (2022)

Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation
por: Osawa, Takumi, et al.
Publicado: (2021)

Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation
por: Conti, Sergio, et al.
Publicado: (2023)

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
por: Burnett, Allison E., et al.
Publicado: (2016)

Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review
por: Sunkara, Tagore, et al.
Publicado: (2016)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pnc8lq2hapqis1nioqphubl0qs